Latest Myopia News

CooperVision’s New Research Confirms Success of Myopic Defocus in High Myopes Using MiSight 1 Day

October 25, 2022

Paul Chamberlain, BSc (Hons), Senior Director of Research Programs, CooperVision, will present the latest research findings at Academy 2022.

SAN RAMON, Calif. — In new research being presented at the 2022 American Academy of Optometry (AAO) annual meeting this week, CooperVision shared new insights regarding its MiSight 1 day contact lenses. The most recent study looked at high myopes’ accommodative behavior and retinal performance when wearing MiSight 1 day, and the findings demonstrated that the dual focus optical design was able to introduce myopic defocus at all viewing distances.

With newly expanded parameters  (up to –7.00D in the United States; up to –10.00D in select markets), eye care professionals can confidently treat more age-appropriate* children impacted by the growing prevalence and severity of myopia.1

These scientific works examine highly myopic eyes (–6.50D to –10.00D, mean ± SD: –8.00±1.02D) fit with single-vision and MiSight 1 day lenses, revealing that eyes accommodated similarly in both cases. Small accommodative leads at distance did not prevent +2.00D myopic defocus in the MiSight 1 day treatment optics from being imposed on the retina. Researchers also found that higher powers did not prevent the lens from reducing hyperopic retinal defocus across the central 40 degrees of the horizontal retina.

The latest findings from CooperVision highlight how MiSight 1 day contact lenses affect myopic defocus.

“CooperVision has invested decades into myopia research and development to provide evidence-based interventions for children with this disease,” said Paul Chamberlain, BSc (Hons), Senior Director of Research Programs, CooperVision. “Combining these latest findings with our extensive and rigorous body of existing work helps eye care professionals take on myopia with more confidence, reaching even more children around the world.”



*Indications for use: MiSight 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters(spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal

† Availability of specific expanded range parameters may vary by country

1 Holden et al, Global Prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 2016. 123(5):1036-1042

To Top